ABL1 and Parkinson disease: Since c-Abl is known to be activated under PD pathological conditions, the c-Abl-PARIS pathway may contribute to the heightened vulnerability of dopaminergic neurons to PARIS-induced toxicity compared to cortical neurons in CamKIIα-tTA;TetP-PARIS mice [8].